U.S. GLOBAL INVESTORS INC-A (GROW)

US9029521005 - Common Stock

2.46  +0.02 (+0.82%)

Fundamental Rating

4

Taking everything into account, GROW scores 4 out of 10 in our fundamental rating. GROW was compared to 219 industry peers in the Capital Markets industry. No worries on liquidiy or solvency for GROW as it has an excellent financial health rating, but there are worries on the profitability. GROW does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

In the past year GROW was profitable.
GROW had a positive operating cash flow in the past year.
GROW had positive earnings in 4 of the past 5 years.
GROW had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

GROW has a Return On Assets (3.57%) which is in line with its industry peers.
With a Return On Equity value of 3.77%, GROW is not doing good in the industry: 68.69% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 3.57%
ROE 3.77%
ROIC N/A
ROA(3y)4.7%
ROA(5y)8.1%
ROE(3y)5.03%
ROE(5y)9.22%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GROW's Profit Margin of 36.56% is fine compared to the rest of the industry. GROW outperforms 77.10% of its industry peers.
GROW's Profit Margin has declined in the last couple of years.
GROW does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 36.56%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-32.22%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

The number of shares outstanding for GROW has been reduced compared to 1 year ago.
The number of shares outstanding for GROW has been reduced compared to 5 years ago.
GROW has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 9.05 indicates that GROW is not in any danger for bankruptcy at the moment.
GROW has a better Altman-Z score (9.05) than 95.79% of its industry peers.
There is no outstanding debt for GROW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.05
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 20.96 indicates that GROW has no problem at all paying its short term obligations.
GROW has a Current ratio of 20.96. This is amongst the best in the industry. GROW outperforms 98.13% of its industry peers.
GROW has a Quick Ratio of 20.96. This indicates that GROW is financially healthy and has no problem in meeting its short term obligations.
GROW has a Quick ratio of 20.96. This is amongst the best in the industry. GROW outperforms 98.13% of its industry peers.
Industry RankSector Rank
Current Ratio 20.96
Quick Ratio 20.96

1

3. Growth

3.1 Past

GROW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.72%.
The earnings per share for GROW have been decreasing by -64.61% on average. This is quite bad
The Revenue for GROW has decreased by -64.52% in the past year. This is quite bad
Measured over the past years, GROW shows a quite strong growth in Revenue. The Revenue has been growing by 8.69% on average per year.
EPS 1Y (TTM)-34.72%
EPS 3Y-64.61%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-64.52%
Revenue growth 3Y-48.83%
Revenue growth 5Y8.69%
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.92, the valuation of GROW can be described as rather expensive.
GROW's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.41. GROW is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.92
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

GROW has a Yearly Dividend Yield of 3.69%.
GROW's Dividend Yield is comparable with the industry average which is at 9.65.
Compared to an average S&P500 Dividend Yield of 2.33, GROW pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.69%

5.2 History

The dividend of GROW is nicely growing with an annual growth rate of 24.71%!
GROW has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of GROW decreased recently.
Dividend Growth(5Y)24.71%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

GROW pays out 69.08% of its income as dividend. This is not a sustainable payout ratio.
DP69.08%
EPS Next 2YN/A
EPS Next 3YN/A

U.S. GLOBAL INVESTORS INC-A

NASDAQ:GROW (1/3/2025, 8:00:01 PM)

2.46

+0.02 (+0.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-06 2025-02-06
Inst Owners30.9%
Inst Owner Change3.57%
Ins Owners5.61%
Ins Owner Change1.18%
Market Cap33.65M
Analysts0
Price TargetN/A
Short Float %0.44%
Short Ratio1.01
Dividend
Industry RankSector Rank
Dividend Yield 3.69%
Dividend Growth(5Y)24.71%
DP69.08%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-17 2025-03-17 (0.0075)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.92
Fwd PE N/A
P/S 6.75
P/FCF N/A
P/OCF 275.84
P/B 0.7
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)0.13
EY5.28%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.01
OCFY0.36%
SpS0.36
BVpS3.54
TBVpS3.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.57%
ROE 3.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 36.56%
GM N/A
FCFM N/A
ROA(3y)4.7%
ROA(5y)8.1%
ROE(3y)5.03%
ROE(5y)9.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-32.22%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.96
Quick Ratio 20.96
Altman-Z 9.05
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.01%
Profit Quality(3y)150.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.72%
EPS 3Y-64.61%
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-64.52%
Revenue growth 3Y-48.83%
Revenue growth 5Y8.69%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-359.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-100.35%
FCF growth 3Y-45.12%
FCF growth 5YN/A
OCF growth 1Y-98.69%
OCF growth 3Y-40.79%
OCF growth 5YN/A